HOME › DRUGS › IBREXAFUNGERP CITRATE
ACTIVE SUBSTANCE / INN

IBREXAFUNGERP CITRATE

Brand name(s): BREXAFEMME
FDA LISTED
PRESCRIPTION
NDA214900
ACTIVE SUBSTANCE
Ibrexafungerp Citrate
REGULATORS
FDA
SPONSORS / MAH
GLAXOSMITHKLINE
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BREXAFEMMENDA214900GLAXOSMITHKLINEPrescription

FULL INTELLIGENCE ON IBREXAFUNGERP CITRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →